Sánchez Atlas of Dermatology in Internal Medicine
1. Auflage 2011
ISBN: 978-1-4614-0688-4
Verlag: Springer US
Format: PDF
Kopierschutz: 1 - PDF Watermark
E-Book, Englisch, 148 Seiten, eBook
ISBN: 978-1-4614-0688-4
Verlag: Springer US
Format: PDF
Kopierschutz: 1 - PDF Watermark
Atlas of Dermatology in Internal Medicine is the only concise text-atlas to cover the most common and most important cutaneous manifestations of systemic disease in children and adults. It features more than 150 clinical photographs that are accompanied by format-driven, clinically focused text on the diagnosis and management of cutaneous manifestations of connective tissue, pulmonary, renal, GI, endocrine, malignant, infectious, and HIV disease. There is also a separate chapter on skin diseases commonly seen in the ICU. A special feature is its systematic coverage of clinically relevant dermatopathology. The book is a helpful tool for physicians and trainees in internal medicine, family medicine, pediatrics, emergency medicine, and critical care medicine, as well as family, emergency, and critical care nurse practitioners.
NéstorP. Sánchez, MDProfessor of Pathology and Dermatology and chairmanDepartment of DermatologyUniversity of Puerto RicoMedical Sciences CampusSchool of MedicineSan Juan, Puerto Rico
Zielgruppe
Professional/practitioner
Autoren/Hrsg.
Weitere Infos & Material
1;Atlas of Dermatologyin Internal Medicine;3
1.1;Preface;7
1.2;Acknowledgments;9
1.3;Contents;11
1.4;Contributors;13
1.5;Cutaneous Manifestations of Connective Tissue Diseases;15
1.5.1;Introduction;15
1.5.2;Systemic Lupus Erythematosus;15
1.5.2.1;Acute Cutaneous Lupus Erythematosus;15
1.5.2.2;Subacute Cutaneous Lupus Erythematosus;15
1.5.2.3;Chronic Cutaneous Lupus Erythematosus;16
1.5.2.4;Bullous Systemic Lupus Erythematosus;17
1.5.2.5;Classification and Treatment;17
1.5.3;Dermatomyositis;18
1.5.3.1;Classification and Treatment;20
1.5.4;Scleroderma;20
1.5.4.1;Systemic Sclerosis;20
1.5.4.2;Morphea or Localized Scleroderma;22
1.5.4.3;Classification and Treatment;23
1.5.5;Rheumatoid Arthritis;24
1.5.5.1;Introduction;24
1.5.5.1.1;Classic Rheumatoid Nodules;24
1.5.5.1.2;Accelerated Rheumatoid Nodulosis;25
1.5.5.1.3;Rheumatoid Nodulosis;26
1.5.5.1.4;Rheumatoid Vasculitis;26
1.5.5.1.5;Pyoderma Gangrenosum;27
1.5.5.1.6;Interstitial Granulomatous Dermatitis with Arthritis;28
1.5.5.1.7;Palisaded Neutrophilic Granulomatous Dermatitis;28
1.5.6;Conclusion;29
1.5.7;References;29
1.6;Cutaneous Manifestations of Pulmonary Disease;31
1.6.1;Sarcoidosis;31
1.6.2;Specific Sarcoidosis;32
1.6.2.1;Lupus Pernio (Besnier–Boeck–Schaumann Disease);32
1.6.2.2;Papules, Macules, Nodules, and Plaques;32
1.6.2.3;Subcutaneous Nodules (Darier–Roussy);33
1.6.2.4;Scar Sarcoidosis;33
1.6.2.5;Alopecia;35
1.6.2.6;Ichthyosiform Sarcoidosis;35
1.6.2.7;Hypopigmentation;35
1.6.3;Nonspecific Sarcoidosis;35
1.6.3.1;Erythema Nodosum;35
1.6.4;Other;35
1.6.4.1;Nail, Mucosal, and Childhood Sarcoidosis;35
1.6.4.1.1;Treatment;36
1.6.5;Tuberculosis;36
1.6.6;True Cutaneous Tuberculosis;37
1.6.6.1;Endogenously Acquired Disease;37
1.6.6.1.1;Lupus Vulgaris;37
1.6.6.1.2;Scrofuloderma;38
1.6.6.1.3;Acute Miliary Tuberculosis;38
1.6.6.1.4;Orificial Tuberculosis;39
1.6.6.2;Exogenously Acquired Disease;39
1.6.6.2.1;Tuberculous Chancre;39
1.6.6.2.2;Tuberculosis Verrucosa Cutis;39
1.6.7;Tuberculids;39
1.6.7.1;Lichen Scrofulosorum;40
1.6.7.2;Erythema Induratum of Bazin;40
1.6.7.3;Papulonecrotic Tuberculid;40
1.6.7.4;Nodular Tuberculid;40
1.6.7.4.1;Treatment;40
1.6.8;Birt–Hogg–Dubé Syndrome;40
1.6.8.1;Fibrofolliculoma;41
1.6.8.2;Trichodiscomas;41
1.6.8.3;Acrochordons;41
1.6.9;Cystic Fibrosis;41
1.6.10;References;42
1.7;Cutaneous Manifestations of Renal Disease;45
1.7.1;Introduction;45
1.7.2;General Changes;45
1.7.3;Uremic Pruritus;45
1.7.4;Calcinosis Cutis;46
1.7.5;Calciphylaxis;47
1.7.6;Nephrogenic Systemic Fibrosis;48
1.7.7;Bullous Disease of Hemodialysis;49
1.7.7.1;Porphyria Cutanea Tarda;49
1.7.7.2;Pseudoporphyria;49
1.7.8;Conclusion;50
1.7.9;References;50
1.8;Cutaneous Manifestations of Gastrointestinal Diseases;55
1.8.1;Inflammatory Bowel Disease;55
1.8.1.1;Erythema Nodosum;55
1.8.1.2;Pyoderma Gangrenosum;57
1.8.1.3;Sweet’s Syndrome;58
1.8.2;Nutritional and Metabolic Disorders;59
1.8.2.1;Dermatitis Herpetiformis;59
1.8.2.2;Lichen Planus;60
1.8.3;Gastrointestinal Hemorrhage;61
1.8.3.1;Kaposi’s Sarcoma;61
1.8.4;Gastrointestinal Neoplasias;61
1.8.4.1;Gardner’s Syndrome;61
1.8.4.2;Müir–Torre Syndrome;62
1.8.4.3;Peutz–Jeghers Syndrome;63
1.8.4.4;Bazex’s Syndrome;63
1.8.4.5;Necrolytic Migratory Erythema;63
1.8.5;Conclusions;64
1.8.6;References;64
1.9;Cutaneous Manifestations of Common Endocrine Disease;66
1.9.1;Thyroid Disease;66
1.9.1.1;Hyperthyroidism;66
1.9.1.2;Hypothyroidism;67
1.9.2;Diabetes Mellitus;68
1.9.2.1;Acanthosis Nigricans;68
1.9.2.2;Necrobiosis Lipoidica Diabeticorum;68
1.9.2.3;Miscellaneous Conditions;69
1.9.3;Adrenal Disorders;69
1.9.4;Conclusion;71
1.9.5;References;71
1.10;Cutaneous Manifestations of Internal Malignancy and Paraneoplastic Syndromes;72
1.10.1;Cutaneous Metastasis of Internal Malignancies;72
1.10.2;Sister (Mary) Joseph’s Nodule;74
1.10.3;Cutaneous Manifestations of Internal Malignancies: Symptoms, Signs, and Other Distinct Disease Entities;75
1.10.4;Paget’s Disease of the Breast and Extramammary Paget’s Disease;75
1.10.5;Paraneoplastic Syndromes: A Brief Overview;77
1.10.6;Acanthosis Nigricans;77
1.10.7;The Sign of Leser–Trélat;78
1.10.8;Tripe Palms (Pachydermatoglyphy);78
1.10.9;Acrokeratosis Paraneoplastica (Bazex’s Syndrome);79
1.10.10;Necrolytic Migratory Erythema;79
1.10.11;Erythema Gyratum Repens;81
1.10.12;Acute Febrile Neutrophilic Dermatosis (Sweet’s Syndrome);81
1.10.13;Acquired Ichthyosis;84
1.10.14;Paraneoplastic Pemphigus;84
1.10.15;Conclusion;85
1.10.16;References;85
1.11;Cutaneous Manifestations of Infectious Diseases;90
1.11.1;Bacteria, Spirochetes, and Mycobacteria (Table 1);90
1.11.1.1;Bacteria;90
1.11.1.1.1;Impetigo;90
1.11.1.1.2;Folliculitis;90
1.11.1.1.2.1;Introduction;90
1.11.1.1.2.2;Incidence and Prevalence;90
1.11.1.1.2.3;Etiology;90
1.11.1.1.2.4;Clinical Features;90
1.11.1.1.2.5;Diagnosis;91
1.11.1.1.2.6;Pathology;91
1.11.1.1.2.7;Differential Diagnosis;91
1.11.1.1.2.8;Complications;91
1.11.1.1.2.9;Treatment;92
1.11.1.1.3;Furuncles and Carbuncles;93
1.11.1.1.3.1;Introduction;93
1.11.1.1.3.2;Clinical Features;93
1.11.1.1.3.3;Etiology;93
1.11.1.1.3.4;Diagnosis;93
1.11.1.1.3.5;Pathology;94
1.11.1.1.3.6;Differential Diagnosis;94
1.11.1.1.3.7;Complications;94
1.11.1.1.3.8;Treatment;94
1.11.1.1.4;Cellulitis;94
1.11.1.1.4.1;Introduction;94
1.11.1.1.4.2;Incidence and Prevalence;94
1.11.1.1.4.3;Etiology;94
1.11.1.1.4.4;Clinical Features;96
1.11.1.1.4.5;Diagnosis;96
1.11.1.1.4.6;Pathology;96
1.11.1.1.4.7;Differential Diagnosis;96
1.11.1.1.4.8;Complications;96
1.11.1.1.4.9;Treatment;96
1.11.1.1.5;Methicillin-Resistant S. aureus;97
1.11.1.1.5.1;Introduction;97
1.11.1.1.5.2;Incidence and Prevalence;97
1.11.1.1.5.3;Etiology;97
1.11.1.1.5.4;Clinical Features;97
1.11.1.1.5.5;Diagnosis;97
1.11.1.1.5.6;Treatment;97
1.11.1.1.6;Erysipelas;98
1.11.1.1.6.1;Introduction;98
1.11.1.1.6.2;Etiology;98
1.11.1.1.6.3;Pathology;98
1.11.1.1.6.4;Differential Diagnosis;98
1.11.1.1.6.5;Complications;98
1.11.1.1.6.6;Treatment;98
1.11.1.1.7;Ecthyma;98
1.11.1.1.7.1;Introduction;98
1.11.1.1.7.2;Incidence and Prevalence;99
1.11.1.1.7.3;Etiology;99
1.11.1.1.7.4;Clinical Features;99
1.11.1.1.7.5;Diagnosis;99
1.11.1.1.7.6;Pathology;99
1.11.1.1.7.7;Differential Diagnosis;99
1.11.1.1.7.8;Complications;99
1.11.1.1.7.9;Treatment;99
1.11.1.1.8;Ecthyma Gangrenosum;99
1.11.1.1.8.1;Introduction;99
1.11.1.1.8.2;Incidence and Prevalence;99
1.11.1.1.8.3;Etiology;99
1.11.1.1.8.4;Clinical Features;99
1.11.1.1.8.5;Diagnosis;99
1.11.1.1.8.6;Pathology;100
1.11.1.1.8.7;Differential Diagnosis;100
1.11.1.1.8.8;Complications;100
1.11.1.1.8.9;Treatment;100
1.11.1.1.9;Staphylococcal Scalded Skin Syndrome;100
1.11.1.1.9.1;Introduction;100
1.11.1.1.9.2;Incidence and Prevalence;100
1.11.1.1.9.3;Etiology;100
1.11.1.1.9.4;Clinical Features;100
1.11.1.1.9.5;Diagnosis;100
1.11.1.1.9.6;Pathology;101
1.11.1.1.9.7;Differential Diagnosis;101
1.11.1.1.9.8;Complications;101
1.11.1.1.9.9;Treatment;101
1.11.1.1.10;Toxic Shock Syndrome;102
1.11.1.1.10.1;Introduction;102
1.11.1.1.10.2;Incidence and Prevalence;102
1.11.1.1.10.3;Etiology;102
1.11.1.1.10.4;Clinical Features;102
1.11.1.1.10.5;Diagnosis;102
1.11.1.1.10.6;Pathology;103
1.11.1.1.10.7;Differential Diagnosis;103
1.11.1.1.10.8;Complications;103
1.11.1.1.10.9;Treatment;103
1.11.1.1.11;Blistering Distal Dactylitis;104
1.11.1.1.11.1;Introduction;104
1.11.1.1.11.2;Incidence and Prevalence;104
1.11.1.1.11.3;Etiology;104
1.11.1.1.11.4;Clinical Features;104
1.11.1.1.11.5;Diagnosis;104
1.11.1.1.11.6;Differential Diagnosis;104
1.11.1.1.11.7;Treatment;104
1.11.1.1.12;Necrotizing Soft Tissue Infections;104
1.11.1.1.12.1;Introduction;104
1.11.1.1.12.2;Etiology;105
1.11.1.1.12.3;Clinical Features;105
1.11.1.1.12.4;Diagnosis;106
1.11.1.1.12.5;Pathology;106
1.11.1.1.12.6;Differential Diagnosis;106
1.11.1.1.12.7;Complications;106
1.11.1.1.12.8;Treatment;106
1.11.1.1.13;Rhinoscleroma;107
1.11.1.1.13.1;Introduction;107
1.11.1.1.13.2;Incidence and Prevalence;107
1.11.1.1.13.3;Etiology;107
1.11.1.1.13.4;Clinical Features;107
1.11.1.1.13.5;Diagnosis;107
1.11.1.1.13.6;Pathology;107
1.11.1.1.13.7;Differential Diagnosis;107
1.11.1.1.13.8;Complications;107
1.11.1.1.13.9;Treatment;107
1.11.1.2;Spirochetes;107
1.11.1.2.1;Leptospirosis;107
1.11.1.2.1.1;Introduction;107
1.11.1.2.1.2;Incidence and Prevalence;107
1.11.1.2.1.3;Etiology;108
1.11.1.2.1.4;Clinical Features;108
1.11.1.2.1.5;Diagnosis;108
1.11.1.2.1.6;Pathology;108
1.11.1.2.1.7;Differential Diagnosis;108
1.11.1.2.1.8;Complications;108
1.11.1.2.1.9;Treatment;108
1.11.1.2.2;Lyme Disease;109
1.11.1.2.2.1;Introduction;109
1.11.1.2.2.2;Incidence and Prevalence;109
1.11.1.2.2.3;Etiology;109
1.11.1.2.2.4;Clinical Features;109
1.11.1.2.2.5;Diagnosis;110
1.11.1.2.2.6;Pathology;110
1.11.1.2.2.7;Differential Diagnosis;110
1.11.1.2.2.8;Complications;110
1.11.1.2.2.9;Treatment;110
1.11.1.3;Mycobacteria;111
1.11.1.3.1;Hansen’s Disease;111
1.11.1.3.1.1;Introduction;111
1.11.1.3.1.2;Incidence and Prevalence;111
1.11.1.3.1.3;Etiology;111
1.11.1.3.1.4;Clinical Features;111
1.11.1.3.1.5;Diagnosis;111
1.11.1.3.1.6;Differential Diagnosis;113
1.11.1.3.1.7;Complications;113
1.11.1.3.1.8;Treatment;114
1.11.1.3.2;Atypical Mycobacteriosis;114
1.11.1.3.2.1;Introduction;114
1.11.1.3.2.2;Incidence and Prevalence;115
1.11.1.3.2.3;Etiology;115
1.11.1.3.2.4;Clinical Features;116
1.11.1.3.2.5;Diagnosis;116
1.11.1.3.2.6;Treatment;116
1.11.2;Fungal Infections;116
1.11.2.1;Superficial Mycoses;116
1.11.2.1.1;Inflammatory Superficial Mycoses;117
1.11.2.1.1.1;Dermatophytoses;117
1.11.2.1.1.1.1;Introduction;117
1.11.2.1.1.1.2;Incidence and Prevalence;117
1.11.2.1.1.1.3;Etiology;119
1.11.2.1.1.1.4;Diagnosis;119
1.11.2.1.1.1.5;Pathology;119
1.11.2.1.1.1.6;Complications;119
1.11.2.1.1.1.7;Treatment;119
1.11.2.1.1.2;Mucocutaneous Candidiasis;119
1.11.2.1.1.2.1;Introduction;119
1.11.2.1.1.2.2;Etiology;119
1.11.2.1.1.2.3;Clinical Features;119
1.11.2.1.1.2.4;Diagnosis;119
1.11.2.1.1.2.5;Treatment;119
1.11.2.1.2;Non-inflammatory Superficial Mycoses;121
1.11.2.1.2.1;Pityriasis Versicolor;121
1.11.2.1.2.1.1;Introduction;121
1.11.2.1.2.1.2;Incidence and Prevalence;121
1.11.2.1.2.1.3;Etiology;121
1.11.2.1.2.1.4;Clinical Features;122
1.11.2.1.2.1.5;Diagnosis;122
1.11.2.1.2.1.6;Pathology;122
1.11.2.1.2.1.7;Differential Diagnosis;122
1.11.2.1.2.1.8;Treatment;122
1.11.2.2;Subcutaneous Mycoses;123
1.11.2.2.1;Sporotrichosis;123
1.11.2.2.1.1;Introduction;123
1.11.2.2.1.2;Incidence and Prevalence;123
1.11.2.2.1.3;Etiology;123
1.11.2.2.1.4;Clinical Features;123
1.11.2.2.1.5;Diagnosis;124
1.11.2.2.1.6;Pathology;124
1.11.2.2.1.7;Differential Diagnosis;124
1.11.2.2.1.8;Treatment;124
1.11.2.3;Systemic Mycoses;125
1.11.2.3.1;Diagnosis;125
1.11.2.3.2;Treatment Histoplasmosis;125
1.11.2.3.3;Treatment Coccidioidomycosis;125
1.11.2.3.4;Treatment Blastomycosis;125
1.11.2.3.5;Treatment Paracoccidioidomycosis;125
1.11.3;Viral Infections;125
1.11.3.1;Varicella-Zoster Virus;125
1.11.3.1.1;Introduction;125
1.11.3.1.2;Incidence and Prevalence;125
1.11.3.1.3;Etiology;125
1.11.3.1.4;Clinical Features: Varicella;127
1.11.3.1.5;Clinical Features: Herpes Zoster;127
1.11.3.1.6;Diagnosis;128
1.11.3.1.7;Differential Diagnosis;128
1.11.3.1.8;Complications;128
1.11.3.1.9;Treatment;129
1.11.4;References;129
1.12;Cutaneous Manifestations of HIV Disease;133
1.12.1;Exanthem of Primary HIV Infection (Acute Retroviral Syndrome);133
1.12.2;Bacillary Angiomatosis;133
1.12.3;Varicella-Zoster Virus;134
1.12.4;Seborrheic Dermatitis;135
1.12.5;Oral Hairy Leukoplakia;136
1.12.6;Mucocutaneous Candidiasis;136
1.12.6.1;Oral Thrush;136
1.12.6.2;Intertriginous Infections;137
1.12.7;Onychomycosis (Tinea Unguium);137
1.12.8;Kaposi’s Sarcoma;137
1.12.9;Molluscum Contagiosum;138
1.12.10;Summary;139
1.12.11;References;139
1.13;Cutaneous Disorders in the Intensive Care Unit;140
1.13.1;Introduction;140
1.13.2;Pathogen-Related Skin Disorders;141
1.13.3;Dermatomycoses: Mucocutaneous Candidiasis;141
1.13.4;Pyoderma: Impetigo;142
1.13.5;Peripheral Vascular Disease-Related Skin Disorders;143
1.13.6;Meningococcal Septicemia;143
1.13.7;Ecthyma Gangrenosum;144
1.13.8;Drug Reaction-Related Skin Disorders;145
1.13.9;Hypersensitivity Syndrome or Drug Reaction with Eosinophilia and Systemic Symptoms;146
1.13.10;Steven–Johnson Syndrome and Toxic Epidermal Necrolysis;148
1.13.11;Hypersensitivity Vasculitis or Leukocytoclastic Vasculitis;150
1.13.12;Conclusion;152
1.13.13;References;152
1.14;Index;154
Contents.- Preface.- List of Contributors.- 1.Cutaneous Manifestations of Connective Tissue Diseases.- 2.Cutaneous Manifestations of Pulmonary Diseases.- 3.Cutaneous Manifestations of Renal Disease.- 4.Cutaneous Manifestations of Gastrointestinal Disease.- 5.Cutaneous Manifestations of Common Endocrine Diseases.- 6.Cutaneous Manifestations of Internal Malignancy and Paraneoplastic Syndromes.- 7.Cutaneous Manifestations of Infectious Diseases.- 8.Cutaneous Manifestations of HIV Disease.- 9.Cutaneous Disorders in the Intensive Care Unit.
